# Charité Universitätsmedizin Berlin

Source: https://onco.cc/institutions/charite/  
OnCo record `charite` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Charité is Europe's largest university hospital, with a Comprehensive Cancer Center and the Berlin Institute of Health.

## Summary

Charité, Universitätsmedizin Berlin, is Europe's largest university hospital and hosts the Charité Comprehensive Cancer Center and the Berlin Institute of Health; it ranks twelfth in the Newsweek/Statista oncology list. Its cancer strengths lie in haematology, cell therapy and translational research carried out with the Max Delbrück Center for Molecular Medicine, with Ulrich Keilholz, Christof von Kalle, Lars Bullinger and the paediatric oncologist Angelika Eggert among its leaders. OnCo links it to the Atlas pathology foundation model developed with Aignostics and Mayo Clinic, to Deutsche Krebshilfe and SIOP Europe, and to the idea of hospital-exemption cell therapies made at scale with a shared registry. Whether academic cell therapy manufacturing can match industry on quality and cost is the open question. Its cell therapy programme is the place to start.

## Fields

- Kind: Institution
- Last checked: 2026-09-04
- Also known as: Charité Comprehensive Cancer Center; Charité Comprehensive Cancer Center (CCCC)
- City: Berlin, DE
- Type: university
- Website: https://www.charite.de

## Sources

- Official website: https://www.charite.de
- PTCOG: particle therapy facilities in operation: https://www.ptcog.site/index.php/facilities-in-operation-public

## Connected records

- technologies: [Atlas (Aignostics, Mayo Clinic, Charité)](https://onco.cc/technologies/atlas-aignostics/), [CyberKnife robotic radiosurgery](https://onco.cc/technologies/cyberknife/), [Proton therapy](https://onco.cc/technologies/proton-therapy/), [Proton therapy machines: cyclotrons, synchrotrons and single-room systems](https://onco.cc/technologies/proton-therapy-systems/), [Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS)](https://onco.cc/technologies/radiosurgery-srs/)
- people: [Angelika Eggert](https://onco.cc/people/angelika-eggert/), [Christof von Kalle](https://onco.cc/people/christof-von-kalle/), [Lars Bullinger](https://onco.cc/people/lars-bullinger/), [Maria De Santis](https://onco.cc/people/maria-de-santis/), [Peter Thuss-Patience](https://onco.cc/people/peter-thuss-patience/), [Ulrich Keilholz](https://onco.cc/people/ulrich-keilholz/)
- key papers: [Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial](https://onco.cc/key-papers/paper-conko-001-adjuvant-gemcitabine-observation-jama-2007/)
- trials: [CONKO-001](https://onco.cc/trials/conko-001/), [CONKO-003 (OFF)](https://onco.cc/trials/conko-003/), [CONKO-005](https://onco.cc/trials/conko-005/), [IntReALL SR 2010](https://onco.cc/trials/intreall-sr-2010/), [PTLD-1](https://onco.cc/trials/ptld-1/)
- ideas: [Hospital-exemption cell therapies at scale, backed by a shared registry](https://onco.cc/ideas/idea-fund-hospital-exemption-registry/)
- institutions: [Deutsche Krebsgesellschaft](https://onco.cc/institutions/deutsche-krebsgesellschaft/), [Deutsche Krebshilfe](https://onco.cc/institutions/deutsche-krebshilfe/), [Deutsches Netzwerk für Personalisierte Medizin](https://onco.cc/institutions/dnpm/), [German Cancer Consortium (DKTK)](https://onco.cc/institutions/dktk/), [Max Delbrück Center for Molecular Medicine](https://onco.cc/institutions/mdc-berlin/), [nationales Netzwerk Genomische Medizin Lungenkrebs](https://onco.cc/institutions/nngm/), [SIOP Europe (European Society for Paediatric Oncology)](https://onco.cc/institutions/siop-europe/)
- companies: [Aignostics](https://onco.cc/companies/aignostics/)

---
JSON: https://onco.cc/api/v1/entities/charite.json